Revisiting social impact models in the COVID-19 era: Improving NCD access through people-centred care to deliver on UHC
To view the recording of this event, click here.
This virtual event will convene the NCD community to:
– Discuss lessons from the COVID-19 pandemic to inform access strategies and business models to improve NCD prevention, treatment and care;
– Understand what social impact means in the context of NCD prevention and control and how it can be achieved through people-centred approaches that meet social and financial objectives;
– Explore relevant approaches to incorporate a people-centred lens to M&E models when designing and implementing health programmes to achieve better health outcomes and deliver shared value;
– Inform the key themes of a NCDA discussion paper on “Rethinking social impact in the context of NCDs to advance a people-centred approach to access”, including a framework to measure shared value in NCD programming.
– Sir Trevor Hassell, President, Healthy Caribbean Coalition (Barbados)
– Ms. Katie Dain, CEO, NCD Alliance (United Kingdom)
– Dr. Bente Mikkelsen, Director, NCD Department, World Health Organization (Switzerland)
– Mr. Christopher Agbega, Our Views, Our Voices Global Advisory Committee (Ghana)
– Mrs. Courtney Roberts, Director, Global Health Philanthropic Partnerships, Eli Lilly and Company (United States)
– Dr. Krishnamurthy Jayanna, Senior Technical Advisor, Karnataka Health Promotion Trust (India)
– Mr. Sebastien Mazzuri, Managing Director, FSG (Switzerland)
– Dr. Gina Agiostratidou, Program Director, Type 1 Diabetes, The Leona M. and Harry B. Helmsley Charitable Trust (United States)